Episode Details

Trump’s newly nominated Drug Czar, Sara Carter, just cleared a key hurdle in the Senate — and her remarks are already shaking up the cannabis industry. Carter has voiced support for medical marijuana and expanded research access, but she stopped short of endorsing federal rescheduling. That silence is raising serious questions about how far the Trump administration plans to go on cannabis reform.In this episode of TDR Cannabis in Five, presented by Dutchie, host Shadd Dales breaks down who Sara Carter is, what her confirmation means for U.S. cannabis policy, and why this nomination could define the direction of federal reform. Reported first by Marijuana Moment, this development isn’t just another D.C. headline — it’s a potential turning point in how Washington handles cannabis.We’ll unpack how the Office of National Drug Control Policy (ONDCP) shapes DEA, DOJ, and HHS coordination, what this nomination signals for rescheduling momentum, and how the politics of 2025 could finally push reform over the finish line.If Carter’s approach aligns with the data-driven tone she’s struck publicly, it could pave the way for smart, bipartisan progress. If not, it could stall the biggest cannabis policy shift in modern history.#CannabisReform #SaraCarter #TrumpAdministration #MarijuanaPolicy #CannabisRescheduling #TDRCannabisInFive #Dutchie #CannabisNews #WeedPolicy #FederalCannabisWant to see last week's recap?   • Weekly Recap: Trump Cannabis Post Sparks S...  Want to see more Cannabis Reform videos?   • Why Virginia Could Be the Next Big Cannabi...     • Marijuana Market Meltdown Michigan's Tax D...     • Republican Senators Push Trump Administrat...     • The Cannabis Gun Rights Ruling That Could ...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook:   / thedalesreport  Twitter: